Hemant Surgical Industries has announced a significant business development, securing a substantial purchase order from the Central Medical Service Society, Ministry of Health and Family Welfare, Government of India. The company is set to supply Ultraportable Handheld portable X-ray Machines along with related utilities, marking a notable achievement in its business operations.

Order Details

• Contract Value: Rs. 82.89 crores (inclusive of all taxes and duties)
• Scope: Supply of Ultraportable Handheld portable X-ray Machines with additional utilities
• Warranty: 3-year warranty included
• Execution Timeline: To be completed in tranches by December 31, 2025

Key Points

• The order comes from a domestic entity, highlighting the company's strong position in the Indian medical equipment market.
• Hemant Surgical Industries will execute the contract in phases, with the final delivery expected by the end of 2025.
• The company has confirmed that there is no involvement of the promoter group in the awarding entity, ensuring transparency in the procurement process.
• The transaction does not fall under related party transactions, further underlining the arm's length nature of the deal.

Market Implications

This significant order is likely to have a positive impact on Hemant Surgical Industries' financial outlook for the coming years. The contract not only provides a substantial boost to the company's order book but also strengthens its position as a key player in the medical equipment sector, particularly in government supplies.

Company's Statement

Hanskumar Shamji Shah, Managing Director of Hemant Surgical Industries Limited, made the announcement through a regulatory filing. The company views this order as a testament to its capabilities in manufacturing and supplying advanced medical equipment to meet the needs of India's healthcare sector.

Conclusion

The securing of this large government contract by Hemant Surgical Industries demonstrates the company's competitive edge in the medical equipment industry. As the healthcare sector continues to expand and modernize, such orders could pave the way for further growth opportunities for the company in the future.

Hemant Surgical Industries Limited , a company listed on the Bombay Stock Exchange (BSE: 543916), has announced significant changes to its board of directors following a board meeting held on August 28, 2025. The company has appointed a new independent director while accepting the resignation of another due to health reasons.

New Appointment

Mr. Manish Kankani has been appointed as an Additional Director in the category of Non-Executive Independent Director, subject to shareholder approval. His appointment is for a term of five years, from August 28, 2025, to August 27, 2030.

Mr. Kankani brings a wealth of experience to the board:

• Practicing Chartered Accountant with 10 years of experience in auditing, taxation, and financial advisory
• Deep expertise in the audit and regulatory framework governing Non-Banking Financial Companies (NBFCs)
• Specialization in statutory, internal, and tax audits, with a strong focus on NBFCs and income tax matters
• Led numerous audit engagements across a wide spectrum of NBFCs and corporate clients
• Expertise in assessing the integrity of financial statements, internal controls, and risk frameworks, helping clients achieve regulatory compliance and operational efficiency

Resignation

The board has accepted the resignation of Mr. Ketan Chandrakant Dave as an Independent Director, effective August 28, 2025. Mr. Dave cited health issues as the reason for his departure. In his resignation letter, Mr. Dave confirmed that there were no other material reasons for his resignation beyond the stated health concerns.

Other Board Decisions

The board meeting, which lasted from 12:30 p.m. to 1:30 p.m., resulted in several other key decisions:

1. Approval of the Directors' Report and Management Discussion and Analysis Report for the financial year ended March 31, 2025
2. Scheduling of the 36th Annual General Meeting for September 23, 2025
3. Appointment of auditors for the financial year 2025-2026:
   • M/s. ADMS and Company as internal auditor
   • M/s. NKM and Associates as secretarial auditor
   • M/s. K Sorathiya & Co as cost auditor

These appointments and changes reflect Hemant Surgical Industries' commitment to maintaining strong corporate governance and ensuring diverse expertise on its board. The addition of Mr. Kankani, with his extensive experience in finance and auditing, particularly in the NBFC sector, is expected to bring valuable insights to the company's operations and financial strategies.

The company has duly informed the BSE Limited of these developments in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.